Dark

Check out our API

ZCMD
Zhongchao Inc. Class A
stock NASDAQ

At Close

Aug 29, 2025

1.00USD-1.892%(-0.02)4,813

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-1.02)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Oct 29, 2021

06:34AM EDT Zhongchao Reports Its Patient Mgmt. System Improves Its Live Cancer Patients Duration Of Therapy By 40% Benzinga

06:30AM EDT Cancer Patients' Duration of Therapy by 40%, Promoting Successful Treatment PR Newswire

Sep 17, 2021

06:31AM EDT Zhongchao Highlights Launch Of Hematology Multidisciplinary Treatment Training Program Benzinga

06:30AM EDT Zhongchao Inc. Launches Hematology MDT Training Platform to Improve Diagnosis PR Newswire

Sep 10, 2021

06:44AM EDT From 6:30: Zhongchao Announces Hematological Tumor Patient Management Business Benzinga

06:33AM EDT Shanghai Zhongxin Medical Technology Launches Hematological Tumor Patient Care Center RTTNews

06:30AM EDT Zhongchao Inc. Announces Hematological Tumor Patient Management Business to PR Newswire

Aug 25, 2021

08:37AM EDT Zhongchao Expands Patient Management Business To Ovarian Cancer Market RTTNews

08:30AM EDT Zhongchao Inc. Expands Patient Management Business to Ovarian Cancer Market PR Newswire

Aug 12, 2021

08:31AM EDT Zhongchao Inc. Builds A Patient DOT Management System PR Newswire

Jul 27, 2021

11:13AM EDT Zhongchao Reports ~100K Users Completed Learnings Through The Breast Cancer Tiered Diagnosis, Treatment Improvement Platform Built, Operated By The co. Benzinga

Jul 1, 2021

08:31AM EDT Zhongchao Inc. Announces Establishment Of New Subsidiary, Ningxia Zhongxin Internet Hospital Co., Ltd. For Patient Management Benzinga

08:30AM EDT Zhongchao Inc. Announces the Establishment of a New Subsidiary Ningxia Zhongxin PR Newswire

Jun 16, 2021

06:38AM EDT Zhongchao Inc. Partners With AbbVie Shanghai For Medical Education Services RTTNews

06:34AM EDT Zhongchao Announces Medical Education Services Agreement With AbbVie Subsidiary; Terms Not Disclosed Benzinga

06:30AM EDT Zhongchao Inc. Partners with a Subsidiary of AbbVie Inc. (NYSE: ABBV) for PR Newswire

Jun 3, 2021

06:36AM EDT Zhongchao Announces On-Going One-Year Leukemia Education Project With Bethune Foundation And BeiGene Shanghai RTTNews

06:31AM EDT Zhongchao Inc. Announces the On-Going One-Year Leukemia Education Project with Bethune Foundation and BeiGene Shanghai Benzinga

06:30AM EDT Zhongchao Inc. Announces the On-Going One-Year Leukemia Education Project with PR Newswire

May 28, 2021

06:37AM EDT Zhongchao Launches New Line Of Business Focusing On Tumor And Rare Disease Patient Management RTTNews

06:30AM EDT Zhongchao Inc. Launched New Line of Business Focusing on Tumor and Rare Disease PR Newswire

Apr 30, 2021

09:08AM EDT Zhongchao FY EPS $0.183 Vs $0.187 Last Year RTTNews

09:04AM EDT Zhongchao Inc. FY20 EPS $0.183, Up From $0.187 YoY, Sales $17.99M, Up From $14.88 YoY Benzinga

09:01AM EDT Zhongchao Inc. Reports the Fiscal Year 2020 Financial Results PR Newswire

Mar 23, 2021

11:47AM EDT The Market Slows Down As Q1 Closes Out Benzinga

Mar 17, 2021

10:14AM EDT Stock Alert: Zhongchao Gains 60 Percent On Renewal Of RTTNews

06:42AM EDT Zhongchao Renews Contract with China Association Of Health Promotion And Education And GlaxoSmithKline To Continue Medical Education PRogram; Financial Details Not Disclosed Benzinga

06:38AM EDT Zhongchao Announces Renewal Of Its Partnership With China Association Of Health Promotion And Education, GlaxoSmithKline RTTNews

06:30AM EDT Zhongchao Renews Contract with China Association of Health Promotion and PR Newswire

Feb 1, 2021

05:10PM EST Investigating Claims Against Zhongchao Inc. and Encourages Investors with Losses to Contact the Firm PR Newswire

Jan 13, 2021

06:36AM EST Zhongchao Reports Co-Sponsorship Of National Annual Conference For Standardized Liver Cancer Diagnosis, Treatment With China Association Of Health Promotion, No Terms Disclosed Benzinga

06:30AM EST Zhongchao Inc. Promotes Standardized Liver Cancer Diagnosis and Treatment with PR Newswire

Jan 12, 2021

03:07PM EST Claims Against Zhongchao Inc. and Encourages Investors with Losses to Contact the Firm PR Newswire

Nov 12, 2020

07:47AM EST Zhongchao Inc. And Takeda Pharmaceutical To 'Expand Scope of Cooperation in China'; Zhongchao To Continue To Serve As Takeda's Vendor And Partner In China Benzinga

06:33AM EST Zhongchao And Takeda Pharma Expand Scope Of Cooperation In China RTTNews

06:31AM EST Zhongchao Inc. and Takeda Pharmaceutical Expand Scope of Cooperation in China PR Newswire

Sep 21, 2020

09:21AM EDT ZHONGCHAO H1'20 EPS $0.06 vs $0.08 In Same Period Last Year, Sales $8.46M vs $6.99M Year Over Year Benzinga

09:15AM EDT Zhongchao Inc. Reports the First Half of Fiscal Year 2020 Financial Results PR Newswire

Aug 21, 2020

06:56AM EDT Zhongchao Offers Advanced Workshops In Partnership With European Wound Management Association RTTNews

06:49AM EDT Zhongchao Inc. Offers Advanced Workshops in Partnership with European Wound PR Newswire

Aug 11, 2020

06:35AM EDT Zhongchao Inc. Develops Live Interactive Courses 'Promoting the Global Initiative for Chronic Obstructive Lung Disease' Benzinga

06:30AM EDT Zhongchao Inc. Develops Live Interactive Courses Promoting the Global PR Newswire

Aug 4, 2020

10:13AM EDT Mid-Morning Market Update: Markets Edge Higher; Emerson Electric Earnings Beat Expectations Benzinga

07:45AM EDT Zhongchao Reports Renewal Of Contract With J&J, No Terms Disclosed Benzinga

07:12AM EDT Zhongchao Inc. Renews Contract with Johnson & Johnson (China) Limited, PR Newswire

Jul 23, 2020

06:31AM EDT Leading Pharma Companies to Carry Out Multi-Year Online Education Project on Diagnosis and Treatment of Primary Liver Cancer PR Newswire

Share